Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis

Nephrology Dialysis Transplantation

Volumn 20, Issue 1, 2005, Pages 96-104

  Neumann, Irmgard ^a   Kain, Renate ^b   Regele, Heinz ^b   Soleiman, Afschin ^b   Kandutsch, Sandra ^b   Meisl, Franz Thomas ^a  

^a Wilhelminenspital ^*  (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

ANCA; Follow up biopsies; Glomerulonephritis; Histopathology; Prognosis; Therapy

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE; PROTEIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; CHRONIC KIDNEY DISEASE; CHRONICITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; CREATININE BLOOD LEVEL; DISEASE ACTIVITY; DOSE RESPONSE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; RELAPSE; REMISSION; RENOVASCULAR DISEASE; RISK ASSESSMENT;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOPSY, NEEDLE; COMBINED MODALITY THERAPY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VASCULITIS;

EID: 13444265164     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh563     Document Type: Article

References (21)

1. Hauer HA, Bajema IM, van Houwelingen HC et al. Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int 2002; 61: 80-89
2. Booth AD, Almond MK, Burns A et al. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis 2003; 41: 776-784
3. Hoffman GS, Kerr GS, Leavitt RY et al. Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116: 488-498
4. Westman K, Bygren PG, Olsson H et al. Relapse rate, renal survival, and cancer morbidtiy in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement. J Am Soc Nephrol 1998; 9: 842-852
5. Hogan SL, Nachman PH, Wilkman AS, Jennette JC, Falk JR. Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 1996; 7: 23-32
6. Franssen CFM, Gans ROB, Arends B et al. Differences between anti-myeloperoxidase and anti-proteinase 3 associated renal disease. Kidney Int 1995; 61: 80-89
7. Bajema IM, Hagen EC, Hermans J et al. Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis. Kidney Int 1999; 56: 1751-1758
8. Hauer H, Bajema IM, van Houlwelingen HC et al. Determinants of outcome in ANCA-associated glomerulonephritis: a prospective clinico-histopathological analysis of 96 patients. Kidney Int 2002; 62: 1732-1742
9. Hauer HA, Bajema IM, Hagen EC et al. Long-term renal injury in ANCA-associated vasculitis: an analysis of 31 patients with follow-up biopsies. Nephrol Dial Transplant 2002; 17: 587-596
10. Aasarod K, Bostad L, Hammerstorm J, Jorstad S, Iversen BM. Renal histopathology and clinical course in 94 patients with Wegener's granulomatosis. Nephrol Dial Transplant 2001; 16: 953-960
11. Vergunst CE, van Gurp E, Hagen CE et al. An index for renal outcome in ANCA-associated glomerulonephritis. Am J Kidney Dis 2003; 41: 532-538
12. Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-192
13. Austin HA, Muenz LR, Joyce KM et al. Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med 1983; 75: 382-391
14. Altman DG. Practical Statistics for Medical Research. Chapman and Hall, 1991
15. Guillevin L, Cordier JF, Lhote F et al. A prospective, multicenter randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis. Arthritis Rheum 1997; 40: 2187-2198
16. Neumann I, Regele H, Kain R, Birck R, Meisl FTh. Glomerular immune deposits are associated with proteinuria in patients with ANCA-associated crescentic glomerulonephritis. Nephrol Dial Transplant 2003; 18: 524-531
17. Franssen CFM, Stegeman CA, Oost-Kort WW et al. Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glomerulonephritis. J Am Soc Nephrol 1998; 9: 1915-1923
18. Remuzzi G, Ruggenenti P, Perico N et al. Chronic renal diseases: renal protective benefits of renin-angiotensin system inhibition. Ann Intern Med 2002; 136: 604-615
19. Gans ROB, Kuizinga MC, Goldschmeding R et al. Clinical features and outcome in patients with glomerulonephritis and antineutrophil cytoplasmic autoantibodies. Nephron 1993; 64: 182-188
20. Vizak A, Rott T, Koselj-Kajtna M, Rozman B, Kaplan-Pavlovcic S, Ferluga D. Histologic and imnumohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity. Am J Kidney Dis 2003; 41: 539-549
21. Slot MC, Tervaert JW, Franssen CF, Stegeman CA. Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement. Kidney Int 2003; 63: 670-677